X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
liver diseases (3) 3
abridged index medicus (2) 2
adult (2) 2
aged (2) 2
antiviral agents - adverse effects (2) 2
antiviral agents - therapeutic use (2) 2
digestive system diseases (2) 2
double-blind method (2) 2
drug therapy (2) 2
drug therapy, combination (2) 2
female (2) 2
genetic aspects (2) 2
genotype & phenotype (2) 2
hepacivirus - genetics (2) 2
hepacivirus - isolation & purification (2) 2
hepatitis (2) 2
hepatitis c (2) 2
hepatitis c, chronic - drug therapy (2) 2
hepatitis c, chronic - virology (2) 2
hepatocellular-carcinoma (2) 2
humans (2) 2
index medicus (2) 2
interferon-alpha - therapeutic use (2) 2
internal medicine (2) 2
male (2) 2
medicine, general & internal (2) 2
middle aged (2) 2
oligopeptides - adverse effects (2) 2
oligopeptides - therapeutic use (2) 2
patient outcomes (2) 2
polyethylene glycols - therapeutic use (2) 2
recombinant proteins (2) 2
ribavirin (2) 2
rna, viral - blood (2) 2
serine proteinase inhibitors - adverse effects (2) 2
serine proteinase inhibitors - therapeutic use (2) 2
young adult (2) 2
adolescent (1) 1
alpha-2b plus ribavirin (1) 1
american patients (1) 1
antiretroviral drugs (1) 1
chronic hepatitis-c (1) 1
chronic infection (1) 1
clinical medicine (1) 1
clinical trials (1) 1
combination (1) 1
committees (1) 1
comparative analysis (1) 1
diagnostic techniques, digestive system (1) 1
digestive system surgical procedures (1) 1
disease, liver (1) 1
diseases (1) 1
diseases, liver (1) 1
dysfunction, liver (1) 1
dysfunctions, liver (1) 1
electronic books (1) 1
employees (1) 1
evaluation (1) 1
evidence-based medicine (1) 1
exanthema - chemically induced (1) 1
fees & charges (1) 1
gastroenterology/ hepatology (1) 1
general (1) 1
genetic-variation (1) 1
genomes (1) 1
genotype (1) 1
genotype-1 patients (1) 1
genotypes (1) 1
handbooks (1) 1
handbooks and manuals (1) 1
health & fitness (1) 1
health & fitness / diseases / general (1) 1
health and fitness (1) 1
health and wellbeing (1) 1
health aspects (1) 1
hemoglobins - analysis (1) 1
hepatitis c virus (1) 1
il28b (1) 1
infections (1) 1
interferon (1) 1
interferon-alpha - adverse effects (1) 1
liver (1) 1
liver cancer (1) 1
liver disease (1) 1
liver dysfunction (1) 1
liver dysfunctions (1) 1
liver transplantation (1) 1
liver--diseases--handbooks, manuals, etc (1) 1
logistic models (1) 1
manuscripts (1) 1
medical (1) 1
medical / clinical medicine (1) 1
medical / diseases (1) 1
medical / evidence-based medicine (1) 1
medical / internal medicine (1) 1
patients (1) 1
peginterferon alfa-2a (1) 1
peginterferon alfa-2b (1) 1
peginterferon alpha-2b (1) 1
peginterferon-alpha-2a (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 14, pp. 1292 - 1303
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 25, pp. 2405 - 2416
In patients with HCV infection and no previous treatment, the addition of telaprevir to peginterferon–ribavirin resulted in higher response rates than those... 
GENETIC-VARIATION | IL28B | MEDICINE, GENERAL & INTERNAL | HEPATOCELLULAR-CARCINOMA | GENOTYPE-1 PATIENTS | PEGINTERFERON ALPHA-2B | AMERICAN PATIENTS | ALPHA-2B PLUS RIBAVIRIN | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Recombinant Proteins | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Young Adult | Serine Proteinase Inhibitors - adverse effects | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Double-Blind Method | Antiviral Agents - therapeutic use | Interferon-alpha - therapeutic use | Logistic Models | Hepatitis C, Chronic - drug therapy | Sequence Analysis, DNA | Antiviral Agents - adverse effects | Aged | Interferon-alpha - adverse effects | Peginterferon alfa-2b | Patient outcomes | Genetic aspects | Hepatitis C | Drug therapy | Comparative analysis | Health aspects | Fees & charges | Antiretroviral drugs | Liver diseases | Clinical trials | Chronic infection | Employees | Infections | Proteinase inhibitors | Genomes | Ribonucleic acid--RNA | Patients | Ribavirin | Liver cancer | Genotype & phenotype | Hepatitis | Skin | Interferon | Genotypes | Pharmaceuticals
Journal Article
Psychosomatics, ISSN 0033-3182, 2011, Volume 51, Issue 2, pp. 137 - 148
Background Interferon-alpha (IFN- α ) treatment frequently induces depression, potentially leading to early dose reductions or a shorter duration of treatment,... 
Internal Medicine | Psychiatry
Journal Article
01/2018, 4, ISBN 0323478743, 547
Well-organized and vibrantly illustrated throughout, Handbook of Liver Disease is a comprehensive yet concise handbook providing authoritative guidance on key... 
eBook
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.